NYSE: CTLT $19 Billion Large-Cap. S&P 500. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 383%. 1 Year Return 88%. 2021 YTD Return 11%. Since Earnings 30%.
The 52 Week Low is $31.04 set on Wed, Mar 18, 2020.
The 52 Week High is $117.61 set on Tue, Jan 12, 2021.
The All-Time High is $117.61 set on Tue, Jan 12, 2021.
Earnings Per Share
Price To Earnings Ratio
Dividend Yield
Dividend Rate
Ex-Dividend Date
Dividend Payment Date
Dividend Frequency
Dividend History
Catalent Inc trades on the NYSE. CTLT's market cap is 19.0 Billion.
Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
For Starters
Track your portfolio and more.
